Work

Proliferative Capacity and Cellular Composition of Apheresis Products Collected From Patients Mobilized Sequentially With Neupogen Then Neupogen Plus Plerixafor

Year: 2011

Type: article

Abstract: Mobilization with Neupogen plus Plerixafor versus Neupogen alone yields a product with more CD34+ stem cells, thus reducing the overall time and cost for stem cell collections. Since the mechanism of action is different for these two mobilizing agents, we determined whether or not there are differences in the proliferative potential and cellular composition of the apheresis products collected after mobilization.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2010.12.151

Authors: R. Siebenlist, S. Sawyer, R. Taylor, J. Treisman, N. Garlie

Institution: Aurora St. Luke's Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650